What is weight management and obesity?
Obesity is now understood as a chronic, relapsing condition influenced by genetics, hormones that regulate appetite, medications, mental health and environment — not simply a matter of willpower. Excess weight raises the risk of type 2 diabetes, heart disease, sleep apnoea, joint problems and several cancers, and effective treatment substantially reduces those risks.
Around one in four adults in England lives with obesity. Assessment involves BMI alongside waist measurement and, more importantly, an evaluation of weight-related health conditions and previous attempts at weight loss. Blood tests check for contributory conditions such as thyroid disease and for complications such as diabetes and fatty liver. Treatment is then matched to the individual, from structured lifestyle support through to medication such as GLP-1 injections and bariatric surgery.
Common symptoms
- BMI of 30 or above, or 27.5+ in higher-risk ethnic groups
- Weight regain after repeated dieting
- Breathlessness or reduced mobility
- Snoring or daytime sleepiness suggesting sleep apnoea
- Joint pain, especially knees and hips
- Low energy and low mood related to weight
- Weight-related conditions such as raised blood pressure or prediabetes
How long will you wait?
NHS access to specialist (tier 3) weight management and new weight-loss injections is limited and uneven, with waits of a year or more common where services exist, and NHS bariatric surgery pathways often taking one to two years overall.
Privately, you can typically start with a specialist or weight-management clinic within 1–2 weeks.
NHS England median referral-to-treatment wait: 12.4 weeks, with 2.5 million people waiting over 18 weeks (May 2026). Individual waits vary by trust and urgency.
Treatment options
- Structured lifestyle programmes. Dietitian-led plans combining nutrition, activity and behavioural change, the foundation of all weight management.
- GLP-1 based medication. Weekly injections such as semaglutide (Wegovy) or tirzepatide (Mounjaro), producing average weight loss of 15–20% alongside lifestyle change.
- Other medication. Orlistat and other agents where injectables are unsuitable.
- Bariatric surgery. Gastric sleeve or bypass for severe obesity, delivering the largest and most durable weight loss and often diabetes remission.
- Psychological support. Addressing emotional eating, binge eating and the mental health impact of living with obesity.
What does private treatment cost?
As a guide, private GLP-1 weight-loss programmes cost around £150–£300 per month including medication and support, a specialist consultation £200–£300, and self-pay bariatric surgery around £9,000–£15,000.
Does health insurance cover weight management and obesity?
Most UK private medical insurers exclude weight-loss treatment: GLP-1 injections for weight (as opposed to diabetes) and bariatric surgery are generally not covered on standard policies, though a few insurers and employer schemes have begun offering weight-management programmes as add-on benefits. Treatment of complications such as sleep apnoea or joint problems is assessed on its own merits. Assume self-funding for weight-loss medication and surgery unless your insurer confirms cover.
Frequently asked questions
Are weight-loss injections safe, and will I regain weight if I stop?
GLP-1 medicines are licensed, well studied and generally safe under proper medical supervision; nausea and digestive upset are the most common side effects and usually settle. They work while you take them — like treatment for blood pressure — so stopping typically leads to gradual weight regain unless strong lifestyle foundations are in place. Buy only from regulated providers with genuine clinical oversight.
Can I get weight-loss injections on the NHS?
Access is limited. Wegovy is available through specialist NHS weight management services for people meeting eligibility criteria, and Mounjaro is being rolled out in primary care in phases, prioritising those with the highest BMI and weight-related conditions. Availability varies by area and demand is high, which is why many people currently opt for regulated private programmes instead.
When is bariatric surgery worth considering?
Surgery is usually considered when BMI is 40 or above — or 35 with conditions such as type 2 diabetes — and other approaches have not achieved lasting results. It produces the largest and most durable weight loss, frequently puts type 2 diabetes into remission, and modern keyhole procedures are safe in experienced centres. It requires lifelong dietary change and follow-up, so good preparation and aftercare matter.